Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platelet Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02415803
What this trial is testing

Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS

Who this might be right for
Non ST Segment Elevation Acute Coronary Syndrome
First Affiliated Hospital of Harbin Medical University 75
Not applicableStudy completedNCT01582217
What this trial is testing

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition

Who this might be right for
Percutaneous Coronary InterventionDual Antiplatelet TherapyAspirin+1 more
Icahn School of Medicine at Mount Sinai 318
Large-scale testing (Phase 3)Ended earlyNCT00991029
What this trial is testing

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Who this might be right for
Ischemic Attack, Transient
University of California, San Francisco 4,881
Post-approval studies (Phase 4)UnknownNCT02224534
What this trial is testing

Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction

Who this might be right for
ST Elevation Myocardial Infarction
Gyeongsang National University Hospital 326
Testing effectiveness (Phase 2)Study completedNCT05944809
What this trial is testing

The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

Who this might be right for
Esophageal CancerIntensity-modulated Radiation TherapyConcurrent Chemoradiotherapy+1 more
JIANYANG WANG 32
Testing effectiveness (Phase 2)Study completedNCT00914368
What this trial is testing

Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis

Who this might be right for
Coronary Artery DiseaseMyocardial InfarctionStent Thrombosis+2 more
Uppsala University 450
Post-approval studies (Phase 4)Study completedNCT00405717
What this trial is testing

Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel

Who this might be right for
Ischemic Heart DiseaseAcute Coronary Syndromes
Shenyang Northern Hospital 1,300
Large-scale testing (Phase 3)Study completedNCT02044146
What this trial is testing

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary Intervention
Ottawa Heart Institute Research Corporation 120
Post-approval studies (Phase 4)Study completedNCT02748330
What this trial is testing

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2
Peking Union Medical College Hospital 40
Post-approval studies (Phase 4)Study completedNCT04483583
What this trial is testing

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Who this might be right for
Coronary Artery Disease
University of Florida 81
Early research (Phase 1)Study completedNCT01557335
What this trial is testing

Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

Who this might be right for
Platelet Aggregation
POZEN 30
Large-scale testing (Phase 3)Study completedNCT00391872
What this trial is testing

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
AstraZeneca 18,624
Post-approval studies (Phase 4)Study completedNCT02942550
What this trial is testing

Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients

Who this might be right for
STEMIMorphineTicagrelor+1 more
Karolinska University Hospital 82
Early research (Phase 1)Study completedNCT01094483
What this trial is testing

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

Who this might be right for
Platelet Inhibition
AstraZeneca 40
Post-approval studies (Phase 4)Study completedNCT03437044
What this trial is testing

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
University of Florida 40
Large-scale testing (Phase 3)Looking for participantsNCT07012629
What this trial is testing

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Who this might be right for
Covert Brain Infarction
Aarhus University Hospital 1,652
Large-scale testing (Phase 3)Study completedNCT01360437
What this trial is testing

Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

Who this might be right for
Coronary Artery DiseaseAcute Coronary Syndrome
University of Patras 44
Testing effectiveness (Phase 2)Ended earlyNCT02895373
What this trial is testing

PGE1 as Additive Anticoagulant in ECMO-Therapy

Who this might be right for
Respiratory Distress Syndrome, AdultExtracorporeal Membrane Oxygenation
Thomas Staudinger 50
Post-approval studies (Phase 4)Study completedNCT01147133
What this trial is testing

Comparison of Generic and Original Formulation of Clopidogrel

Who this might be right for
Coronary Heart DiseasePercutaneous Coronary Intervention
University of Pecs 75
Testing effectiveness (Phase 2)Study completedNCT00767507
What this trial is testing

Maintenance of Platelet Inhibition With Cangrelor

Who this might be right for
Acute Coronary Syndrome (ACS)
The Medicines Company 221
Next Page